ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60077344%3A_____%2F14%3A00429487" target="_blank" >RIV/60077344:_____/14:00429487 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1186/1756-3305-7-77" target="_blank" >http://dx.doi.org/10.1186/1756-3305-7-77</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1186/1756-3305-7-77" target="_blank" >10.1186/1756-3305-7-77</a>

Result language
angličtina
Original language name
ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe
Original language description
Ixodes ricinus transmits bacterial, protozoal and viral pathogens, causing disease and forming an increasing health concern in Europe. ANTIDotE is an European Commission funded consortium of seven institutes, which aims to identify and characterize tickproteins involved in feeding and pathogen transmission. The knowledge gained will be used to develop and evaluate anti-tick vaccines that may prevent multiple human tick-borne diseases. Strategies encompassing anti-tick vaccines to prevent transmission of pathogens to humans, animals or wildlife will be developed with relevant stakeholders with the ultimate aim of reducing the incidence of tick-borne diseases in humans.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EC - Immunology
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)